Distribution of the pathogenicity islands markers (PAIs) in uropathogenic E.coli isolated from children in mofid children hospital

Archives of Pediatric Infectious Diseases

Volumn 1, Issue 2, 2013, Pages 75-79

  Navidinia, Masoumeh ^a   Najar Peerayeh, Shahin ^a   Fallah, Fatemeh ^b   Bakhshi, Bita ^a   Adabian, Saadat ^a   Alimehr, Shadi ^b   Gholinejad, Zari ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Escherichia coli; Genomic islands; Urinary tract infection

Indexed keywords

EID: 84922811828     PISSN: 23221828     EISSN: 23221836     Source Type: Journal    
DOI: 10.5812/pedinfect.9083     Document Type: Article

References (22)

1. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother. 2010; 54(5): 1855-63.
2. Sabate M, Moreno E, Perez T, Andreu A, Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect. 2006; 12(9): 880-6.
3. Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun. 2010; 78(2): 568-85.
4. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol. 2005; 43(8): 3895-900.
5. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A. 2000; 97(16): 8829-35.
6. Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol. 2000; 54: 641-79.
7. Hacker J, Bender L, Ott M, Wingender J, Lund B, Marre R, et al. Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog. 1990; 8(3): 213-25.
8. Karch H, Schubert S, Zhang D, Zhang W, Schmidt H, Olschlager T, et al. A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun. 1999; 67(11): 5994-6001.
9. Schlager TA, Hendley JO, Bell AL, Whittam TS. Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young girls. Infect Immun. 2002; 70(3): 1225-9.
10. Sabarinath A, Deallie C, Belot G, Vanpee G, Matthew V, Sharma R, et al. Antimicrobial Resistance And Phylogenetic Groups Of Commensal Escherichia Coli Isolates From Healthy Pigs In Grenada. Webmed Central. 2011; WMC001942.
11. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology. 2005; 151(Pt 6): 2097-110.
12. Farshad S, Japoni A, Hosseini M. Low distribution of integrons among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz, Iran. Pol J Microbiol. 2008; 57(3): 193-8.
13. Moreno E, Prats G, Sabate M, Perez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother. 2006; 57(2): 204-11.
14. Tager Frey M, Vial PC, Castillo CH, Godoy PM, Hjelle B, Ferres MG. Hantavirus prevalence in the IX Region of Chile. Emerg Infect Dis. 2003; 9(7): 827-32.
15. Shigemura K, Arakawa S, Miura T, Nakano Y, Tanaka K, Fujisawa M. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections. Jpn J Infect Dis. 2008; 61(3): 226-8.
16. Alhaj N, Mariana N, Raha A, Ishak Z. Prevalence of antibiotic resistance among Escherichia coli from different sources in Malaysia. Int J Poultry Sci. 2007; 6(4): 293-7.
17. Brzuszkiewicz E, Bruggemann H, Liesegang H, Emmerth M, Olschlager T, Nagy G, et al. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Esch erichia coli strains. Proc Natl Acad Sci U S A. 2006; 103(34): 12879-84.
18. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun. 2002; 70(6): 3216-26.
19. Parham NJ, Pollard SJ, Chaudhuri RR, Beatson SA, Desvaux M, Russell MA, et al. Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol. 2005; 43(5): 2425-34.
20. Murugan K, Savitha T, Vasanthi S. Retrospective study of antibiotic resistance among uropathogens from rural teaching hospital, Tamilnadu, India. Asian Pacific J Tropical Dis. 2012; 2(5): 375-80.
21. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol. 1990; 172(11): 6175-81.
22. Dobrindt U, Blum-Oehler G, Nagy G, Schneider G, Johann A, Gottschalk G, et al. Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536. Infect Immun. 2002; 70(11): 6365-72.